Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.

@article{Fitzgerald2007EmergingTI,
  title={Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.},
  author={Mary F Fitzgerald and Jonathan C. Fox},
  journal={Drug discovery today},
  year={2007},
  volume={12 11-12},
  pages={479-86}
}
During the past ten years, the pharmaceutical industry has focussed on treating chronic obstructive pulmonary disease (COPD) as distinct to asthma, and no novel anti-inflammatory agents have been launched as therapies for this disease. As our understanding of the pathology of COPD has increased it has been established that the progressive pulmonary inflammation that is associated with COPD relates to disease severity. Thus, it is anticipated that drugs that reduce pulmonary inflammation will… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Beyond corticosteroids: future prospects in the management of inflammation in COPD.

European respiratory review : an official journal of the European Respiratory Society • 2011

Insulin receptor substrate regulation of phosphoinositide 3-kinase.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2011
View 2 Excerpts

Similar Papers

Loading similar papers…